-
-
-
-
-
-
-
Protagenic completes Phytanix separation, reduces liabilities by $6.3 million
-
-
-
-
-
-
-
Protagenic Therapeutics completes Phase 1 dosing for PT00114 compound
-
-
-
-
-
-
-
Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity
-
-
-
-
-
-
-
Protagenic Therapeutics (PTIX) Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million
-
-
-
-
454,339 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

